This inventor holds 1 USPTO granted patent. Top assignee: Cold Spring Harbor Laboratory. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Kurt Haas: Innovator in Single Cell Electroporation
Introduction
Kurt Haas is a notable inventor based in Goshen, NY (US). He has made significant contributions to the field of biotechnology, particularly in the area of single cell electroporation. His innovative work has the potential to advance research in cellular biology and therapeutic applications.
Latest Patents
Kurt Haas holds 1 patent for his invention titled "Single Cell Electroporation." This patent describes an assembly and method for delivering a substance into a single cell. The process involves combining the substance into an electroporation fluid and placing it into a container with a distal opening. The container is positioned near a target cell, and electrical pulses are delivered between a first electrode in the container and a second electrode outside the cell. This method induces temporary pores in the cell membrane, allowing the substance to enter the cell through passive diffusion or active electrophoretic motion.
Career Highlights
Kurt Haas is affiliated with Cold Spring Harbor Laboratory, where he conducts his research and development. His work at this prestigious institution has allowed him to explore innovative techniques in cellular manipulation and substance delivery.
Collaborations
Kurt has collaborated with several talented individuals in his field, including Wun Chey Sin and Ashkan Javaherian. These collaborations have contributed to the advancement of his research and the successful development of his patented technology.
Conclusion
Kurt Haas is a pioneering inventor whose work in single cell electroporation is paving the way for new advancements in biotechnology. His contributions are significant and hold promise for future applications in cellular research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
